Related Experiment Video
Updated: Apr 17, 2026

06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
7.4K
TEG®- or ROTEM®-based individualized goal-directed coagulation algorithms: don't wait--act now!
Critical Care (London, England)
|February 13, 2015
Summary
Viscoelastic assays like thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) can predict massive transfusion needs and mortality in trauma patients. These methods offer promising guidance for individualized coagulation management in major bleeding scenarios.
Area of Science:
- Critical care medicine
- Hematology
- Surgical hemostasis
Background:
- Massive transfusion protocols are critical in managing severe hemorrhage.
- Current coagulation monitoring in trauma is often inadequate.
- Viscoelastic testing offers real-time assessment of hemostasis.
Purpose of the Study:
- To evaluate the utility of TEG® and ROTEM® in trauma patients.
- To assess the predictive value of these assays for massive transfusion and mortality.
- To explore their role in guiding individualized coagulation algorithms.
Main Methods:
- Analysis of trauma patient data utilizing TEG® and ROTEM®.
- Correlation of viscoelastic parameters with transfusion requirements and outcomes.
- Review of existing literature on viscoelastic testing in cardiac surgery and trauma.
Main Results:
- TEG® and ROTEM® can predict massive transfusion needs and mortality in trauma.
- Evidence from cardiac surgery shows outcome benefits in randomized trials.
- Non-randomized studies in trauma suggest similar promise.
Conclusions:
- Viscoelastic testing is a highly promising technique for trauma.
- TEG® and ROTEM® can guide goal-directed, individualized coagulation management.
- These assays may improve patient outcomes in major bleeding, including trauma.
Related Concept Videos
Coagulation
1.7K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.7K
Coagulation
12.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.4K
Venous Thrombosis III: Interprofessional Care
473
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
473
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Clot Retraction and Fibrinolysis
10.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.5K

